Company

Celcuity

Rocket Ship Rating

Rocket Ship Rating: 97 out of 100

Cancer Therapies - PAM Pathway - REVTORPYK™

Also known as Celcuity Inc

Biotech & therapeutics
Medical devices & diagnostics

Business model: B2B
Legal name: Celcuity Inc

celcuity.com (opens in a new tab)

Open relationship map

Claim, correct or request removal

Record updated 29 September 2026

About

Cellular diagnostic testing. Enabling more personalized medicine for targeted therapy selection and drug discovery markets.

Funding snapshot

Total raised: $303MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
Latest round: Round, $50M2023-10-20

Funding rounds

Round, 2023: $50M2023-10-20, SEC form D sold, 2 investors
Round, 2022: $100M2022-05-15, SEC form D sold, 11 investors
Round, 2021: $130M2021-04-08, SEC form D sold, 2 investors
Round, 2021: $5M2021-04-08, SEC form D sold, 1 investor
Round, 2017: $2.6M2017-05-05, SEC form D sold, 38 investors
Round, 2017: $5.9M2017-04-28, SEC form D sold, 39 investors
Round, 2016: $325K2016-02-11, SEC form D sold, 6 investors
Round, 2015: $5.2M2015-12-04, SEC form D sold, 40 investors
Round, 2014: $4M2014-02-28, SEC form D sold, 2 investors